Pazopanib is a no go!
Disappointment abounds
LMS is rare
Being treated for LMS with Pazopanib is rare; get funded fully for it by the drug company (over $6000 per month) is rarer still!
The combination of being treated with Pazopanib whilst having my particular heart problem is in the "Unknown" realm and deemed too risky!
I now will start on Heart Protection medication which will assist my left ventricle of my heart to pump blood more effectively.
The Sarcoma team will consult as to the next best treatment regime. It looks like the next door opening will be chemotherapy.
The next appointment is 2 May. I will know more by then......
Time to raise your glass - let's have a pinot,
Love Your Life,
Georgia
Having a G&T with you.
ReplyDeleteFor me, pazopanib was a complete waste of time, even though it was so easy to take and practically side-effect-free.
ReplyDeleteI was on it for 2 months at the end of 2011 -- and at the first scan, there was so much tumor growth, they yanked me off.
So maybe it's not so bad you get to skip it! Although I know, one person's experience really doesn't apply to another.
Hang in there while they search for the next best thing for you to try. I think that waiting around for the next treatment is the hardest time. You're in limbo, nothing to hang your hat on.